NOTICE: This is an archived press release. Information contained on this page may be outdated. Please refer to our latest press releases for up-to-date information.

Post date: December 12 2014

Statement From A.G. Schneiderman On Decision Blocking Pharmaceutical Manufacturer From Manipulating Alzheimer's Patients

NEW YORK – Attorney General Eric T. Schneiderman released the following statement on today’s decision by the United States District Court for the Southern District of New York, which granted New York’s motion for a preliminary injunction against Defendants Actavis plc and Forest Laboratories LLC.  

"Today’s decision prevents Actavis from pursuing its scheme to block competition and maintain its high drug prices.  Our lawsuit against Actavis sends a clear message: drug companies cannot illegally prioritize profits over patients. We will continue to protect New Yorkers from anticompetitive practices by drug manufacturers.”

Groups audience: